Dyne Therapeutics (DYN) PT Lowered to $45 at Morgan Stanley
Tweet
Share
E-mailGet Alerts DYN Hot Sheet
Price: $25.08 -0.08%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Morgan Stanley analyst Michael E Ulz lowered the price target on Dyne Therapeutics (NASDAQ: DYN) to $45.00 (from $47.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- Comstock Resources (CRK) PT Raised to $17 at BMO Capital
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
